Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22.
Fearon
D T
DT
Wellcome Trust Immunology Unit, University of Cambridge School of Clinical Medicine, United Kingdom.
D000818:Animals; D015703:Antigens, CD / Q000276:immunology*; D018941:Antigens, CD19 / Q000276:immunology*; D000944:Antigens, Differentiation, B-Lymphocyte / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology*; D015815:Cell Adhesion Molecules; D006801:Humans; D016056:Immunodominant Epitopes / Q000276:immunology*; D037102:Lectins; D008213:Lymphocyte Activation; D017464:Receptors, Complement 3d / Q000276:immunology*; D011971:Receptors, Immunologic / Q000276:immunology; D051918:Sialic Acid Binding Ig-like Lectin 2
D015703:Antigens, CD; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte; C497867:CD22 protein, human; D015815:Cell Adhesion Molecules; D016056:Immunodominant Epitopes; D037102:Lectins; D017464:Receptors, Complement 3d; D011971:Receptors, Immunologic; D051918:Sialic Acid Binding Ig-like Lectin 2